Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02907801 · ClinicalTrials.gov registry record · NA
Perception-Action Approach Intervention for Infants With Congenital Muscular Torticollis
A NA study, sponsored by Rosalind Franklin University of Medicine and Science.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT02907801: Clinical Trial NA study, sponsored by Rosalind Franklin University of Medicine and Science.
NCT02907801 is a NA study that was terminated before completion, run by Rosalind Franklin University of Medicine and Science. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02907801, a NA study, was terminated before completion, sponsored by Rosalind Franklin University of Medicine and Science.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
Infants with congenital muscular torticollis (CMT) display postural and functional asymmetry that interferes with their development. The use of the Perception-Action Approach (P-AA) intervention in infants with CMT is supported by a single case report and needs to be researched further to determine its efficacy. This study will investigate the immediate effects of the P-AA intervention on habitual head deviation from midline, active head rotation range of motion, and functional use of both sides of the body in infants with CMT. The participants will be 3 infants with CMT, aged birth to 9 months. A randomized, nonconcurrent A-B multiple baseline design across subjects will be used. The intervention phase will include 5 daily PT sessions, with outcome data collected at the end of each session. It is hypothesized that improvements on all outcome measures will be documented upon the initiation of the P-A Approach intervention, with the most substantial change expected in habitual head deviation from midline measured by still photography.
Primary Outcome
Change in the angle of habitual head deviation from midline assessed in a supine position
Interventions
- BEHAVIORAL Perception-Action Approach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2017-01-10 |
| Est. Completion | 2018-03-26 |
| Phase | NA |
Why NCT02907801 stopped before completion
NCT02907801 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Perception-Action Approach is the first listed.
NCT02907801 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02907801 about?
NCT02907801 is a clinical study titled "Perception-Action Approach Intervention for Infants With Congenital Muscular Torticollis". Infants with congenital muscular torticollis (CMT) display postural and functional asymmetry that interferes with their development. The use of the Perception-Action Approach (P-AA) intervention in infants with CMT is supported by a single case report and needs to be researched further to determine ...
What is the current status of trial NCT02907801?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2017-01-10. Estimated completion is 2018-03-26.
What interventions are being tested in trial NCT02907801?
The interventions under investigation include: Perception-Action Approach (BEHAVIORAL).
Who is sponsoring clinical trial NCT02907801?
This trial is sponsored by Rosalind Franklin University of Medicine and Science, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02907801's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI